StockNews.com started coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Get Rating) in a report released on Thursday morning. The brokerage issued a strong-buy rating on the biopharmaceutical company’s stock. Vanda Pharmaceuticals Trading Up 1.5 % NASDAQ VNDA opened at $6.20 on Thursday. The firm has a market cap of $356.13 million, a price-to-earnings ratio […]
StockNews.com initiated coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Get Rating) in a research note published on Thursday. The firm issued a strong-buy rating on the biopharmaceutical company’s stock. Vanda Pharmaceuticals Stock Down 1.6 % Shares of VNDA opened at $6.11 on Thursday. The company has a 50-day simple moving average of $6.53 and […]
Capital Advisors Ltd. LLC purchased a new stake in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 5,000 shares of the biopharmaceutical company’s stock, valued at approximately $37,000. Several other […]
Vanda Pharmaceuticals (NASDAQ:VNDA – Get Rating) will issue its quarterly earnings data after the market closes on Wednesday, May 3rd. Parties that wish to register for the company’s conference call can do so using this link. Vanda Pharmaceuticals (NASDAQ:VNDA – Get Rating) last announced its quarterly earnings results on Wednesday, February 8th. The biopharmaceutical company […]
Victory Capital Management Inc. increased its position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Rating) by 6.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 292,240 shares of the biopharmaceutical company’s stock after purchasing an additional 18,325 shares during the quarter. Victory Capital Management […]